Penn Pharma provides drug development and manufacturing services for more than 150 healthcare companies in Europe, Japan and America. It also supplies services for clinical trials, such as drug labelling, packing and distribution, and it recently opened a manufacturing plant for potent compounds in South Wales. Under chief executive Richard Yarwood, 59, Penn’s international sales reached £39m in 2013.
|Activity||Pharmaceutical services provider|
|2-yr av intl sales growth pa||48.19%|
|International sales £000s||39,013|
|Total sales £000s||46,784|
* Supplied by company † Annualised figure